Skip to Content

MANX HEALTHCARE SORE THROAT RELIEF SPRAY 1.5MG OROMUCOSAL SPRAY

Active substance(s): BENZOCAINE

View full screen / Print PDF » Download PDF ⇩
Transcript
PATIENT INFORMATION LEAFLET - INFORMATION FOR THE USER

Sore Throat Relief Spray
1.5mg Oromucosal Spray
Benzocaine

Please read this leaflet carefully before you start
using your medicine because it contains
important information for you.
Keep this leaflet. You may need to read it again.
Ask your pharmacist if you need more
information or advice.
You must contact a doctor if your symptoms
worsen or do not improve after 3 days.
If any side effect occurs and it seems serious to
you, or if you notice any side effect not listed in
this leaflet, please tell your doctor or pharmacist.
What is in this leaflet
1. What Sore Throat Relief Spray is and what it
is used for
2. Before you use Sore Throat Relief Spray
3. How to use Sore Throat Relief Spray
4. Possible side effects
5. How to store Sore Throat Relief Spray
6. Further information

1. What Sore Throat Relief Spray is and
what it is used for
Manx Healthcare Sore Throat Relief Spray 1.5mg
Oromucosal Spray (hereinafter referred to as Sore
Throat Relief Spray) is used to relieve the pain of
sore throats. The product contains benzocaine,
which is a local anaesthetic. It has a fast action and
works by numbing the pain of a sore throat.

a sore throat for more than a few days, or if the
throat is so sore that you cannot swallow

had an allergic reaction to any other local
anaesthetic
had an allergic reaction to a sunscreen product.
Important information about some of the
ingredients in this product
This spray contains a small amount of ethanol
(alcohol), less than 100mg per dose.

3. How to use Sore Throat Relief Spray
This medicine is for use by adults and teenagers.
Please follow the handling instructions below:
Shake the container before use
Before use it may be necessary to press the
plunger 2-3 times to activate spray. Do this away
from your face, into a sink
Do not spray into eyes. If you accidentally spray
into eyes, rinse them thoroughly with water.

Fig 1
Resting position (cannot be activated)

Fig 2
Raise nozzle from
vertical to
horizontal position

2. Before you use Sore Throat Relief
Spray
Do not use this medicine if:
you have had an allergic (hypersensitive)
reaction such as rash, itching or wheezing to
benzocaine or any of the other ingredients of
this medicine (see section 6 for other
ingredients)
you have any difficulty breathing, noisy
breathing, or severe difficulty in swallowing
you have a rare blood condition called
methaemoglobinaemia
you are pregnant or breast feeding.
Do not use in children 12 years and under.
Consult your doctor or pharmacist if you have:
a headache, fever (raised temperature) or
nausea for more than a few days

Fig 3
Hold your head upright and
insert the nozzle well into
your mouth. Hold your breath
and press the plunger once
to deliver a single
metered spray.

(continued overleaf)

WIP URN
APPROVED URN
Job
Size
Date
BOH Approval Date
Saved as
Prints

010415-MST01-PIL-03
N/A

Sore Throat Relief Spray PIL - Side 1
210 x 148mm
1 April 2015
14123/03 PIL S1.ai
1 Colour - Black

M1

Dosage:
Adults and Teenagers (13+):
Hold breath and spray twice to the back of the
throat
Repeat every 2-3 hours if required
Do not use more than 8 times a day.
Do not use in children 12 years and under.
Do not use for more than 3 days in a row. If
symptoms do not improve, consult your pharmacist
or doctor.
You should experience temporary numbness in your
throat after using the spray. This means this
medicine is working. Avoid eating or drinking
while your throat is numb.
If you use more of this medicine than you should
If you spray more than you should, and you feel
drowsy or unwell in any way, you must contact a
doctor immediately.

4. Possible side effects
Like all medicines, Sore Throat Relief Spray can
cause side effects, although not everybody gets
them.
If you experience any of the following allergic
reactions stop using the spray and seek immediate
medical advice:
severe rash, itching, swelling of the face, lips or
mouth
shortness of breath or difficulty breathing
Methaemoglobinaemia (a very rare blood
condition) has been reported with benzocaine use.
Reporting of side effects
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible side
effects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side
effects you can help provide more information on
the safety of this medicine.

6. Further Information
What Sore Throat Relief Spray contains
Each metered dose (spray) of this medicine
contains the active benzocaine 1.5mg. It also
contains cetylpyridinium chloride, glycerin, ethanol,
clove bud oil, peppermint, menthol, saccharin
sodium 450, cremophor RH40 (polyethoxylated
castor oil) and purified water.
What Sore Throat Relief Spray looks like and
contents of the pack
The spray is a clear colourless to straw coloured
solution available in a white aluminium can with a
folding arm activator and cap.
Each can contains approximately sixty metered
doses (sprays).
Marketing Authorisation Holder
Manx Pharma Ltd, Taylor Group House, Wedgnock
Lane, Warwick, CV34 5YA, United Kingdom.
Manufacturer
Pharmasol Ltd, North Way, Walworth Industrial
Estate, Andover, Hampshire, SP10 5AZ, UK.
Other Formats
To request a copy of this leaflet in Braille, large print
or audio please call 01926 482511.
This leaflet was last revised in
April 2015

WIP URN: 010415-MST01-PIL-03

5. How to store Sore Throat Relief Spray
Keep out of the sight and reach of children.
Do not store above 25ÂșC.
Do not use the spray after the expiry date which is
printed on the pack.
Medicines should not be disposed of via wastewater
or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These
measures will help to protect the environment.

WIP URN
APPROVED URN
Job
Size
Date
BOH Approval Date
Saved as
Prints

010415-MST01-PIL-03
N/A

Sore Throat Relief Spray PIL - Side 2
210 x 148mm
1 April 2015
14123/03 PIL S2.ai
1 Colour - Black

M1

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide